as documented at furious seasons , the state of arkansas has leveled some very serious allegations at johnson johnson , manufacturer of risperdal via its subsidiary janssen furious seasons was kind enough to post a copy of the lawsuit here 's a partial listing of the allegations j j hid the extrapyramidal side effects of the medication through conducting scientifically bogus studies which covered up the risks of risperdal j j marketed risperdal off label for such conditions as adhd , depression , anxiety , and aggression associated with dementia j j falsely represented risperdal as cheaper and more effective than older antipsychotics j j did not represent their own knowledge that risperdal is associated with weight gain j j offered kickbacks to physicians to prescribe risperdal for non medically necessary uses the lawsuit makes for interesting and inflammatory reading keep a couple of things in mind when considering these charges zyprexa was clearly marketed off label for various conditions , , it seems that lilly was involved in hiding the risks associated with zyprexa , bristol myers squibb just settled a large lawsuit , partially regarding claims that it promoted abilify off label take a look at a couple studies , that were designed to encourage off label prescription of antipsychotics as well as a scientific review of relevant literature on antipsychotic off label use and of course , there are several states i 've lost count of exactly how many that are suing lilly for its promotion of zyprexa and its alleged concealment of risks associated with the drug i do n't know about you , but i think i'm seeing a pattern emerging here and while we 're talking about weight gain , diabetes and the like , i hope you all have a fantastic thanksgiving